Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.

Cystic Fibrosis (CF) is characterized by chronically inflamed airways, and inflammation even increases during pulmonary exacerbations. These adverse events have an important influence on the well-being, quality of life, and lung function of patients with CF. Prediction of exacerbations by inflammato...

Full description

Bibliographic Details
Main Authors: Marieke van Horck, Ariel Alonso, Geertjan Wesseling, Karin de Winter-de Groot, Wim van Aalderen, Han Hendriks, Bjorn Winkens, Ger Rijkers, Quirijn Jöbsis, Edward Dompeling
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4822839?pdf=render
_version_ 1818050679052173312
author Marieke van Horck
Ariel Alonso
Geertjan Wesseling
Karin de Winter-de Groot
Wim van Aalderen
Han Hendriks
Bjorn Winkens
Ger Rijkers
Quirijn Jöbsis
Edward Dompeling
author_facet Marieke van Horck
Ariel Alonso
Geertjan Wesseling
Karin de Winter-de Groot
Wim van Aalderen
Han Hendriks
Bjorn Winkens
Ger Rijkers
Quirijn Jöbsis
Edward Dompeling
author_sort Marieke van Horck
collection DOAJ
description Cystic Fibrosis (CF) is characterized by chronically inflamed airways, and inflammation even increases during pulmonary exacerbations. These adverse events have an important influence on the well-being, quality of life, and lung function of patients with CF. Prediction of exacerbations by inflammatory markers in exhaled breath condensate (EBC) combined with early treatment may prevent these pulmonary exacerbations and may improve the prognosis.To investigate the diagnostic accuracy of a set of inflammatory markers in EBC to predict pulmonary exacerbations in children with CF.In this one-year prospective observational study, 49 children with CF were included. During study visits with an interval of 2 months, a symptom questionnaire was completed, EBC was collected, and lung function measurements were performed. The acidity of EBC was measured directly after collection. Inflammatory markers interleukin (IL)-6, IL-8, tumor necrosis factor α (TNF-α), and macrophage migration inhibitory factor (MIF) were measured using high sensitivity bead based flow immunoassays. Pulmonary exacerbations were recorded during the study and were defined in two ways. The predictive power of inflammatory markers and the other covariates was assessed using conditionally specified models and a receiver operating characteristic curve (SAS version 9.2). In addition, k-nearest neighbors (KNN) algorithm was applied (SAS version 9.2).Sixty-five percent of the children had one or more exacerbations during the study. The conditionally specified models showed an overall correct prediction rate of 55%. The area under the curve (AUC) was equal to 0.62. The results obtained with the KNN algorithm were very similar.Although there is some evidence indicating that the predictors outperform random guessing, the general diagnostic accuracy of EBC acidity and the EBC inflammatory markers IL-6, IL-8, TNF-α and MIF is low. At present it is not possible to predict pulmonary exacerbations in children with CF with the chosen biomarkers and the method of EBC analysis. The biochemical measurements of EBC markers should be improved and other techniques should be considered.
first_indexed 2024-12-10T10:57:18Z
format Article
id doaj.art-da2458b4334142018aa9044dd5f94eef
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T10:57:18Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-da2458b4334142018aa9044dd5f94eef2022-12-22T01:51:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01114e015215610.1371/journal.pone.0152156Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.Marieke van HorckAriel AlonsoGeertjan WesselingKarin de Winter-de GrootWim van AalderenHan HendriksBjorn WinkensGer RijkersQuirijn JöbsisEdward DompelingCystic Fibrosis (CF) is characterized by chronically inflamed airways, and inflammation even increases during pulmonary exacerbations. These adverse events have an important influence on the well-being, quality of life, and lung function of patients with CF. Prediction of exacerbations by inflammatory markers in exhaled breath condensate (EBC) combined with early treatment may prevent these pulmonary exacerbations and may improve the prognosis.To investigate the diagnostic accuracy of a set of inflammatory markers in EBC to predict pulmonary exacerbations in children with CF.In this one-year prospective observational study, 49 children with CF were included. During study visits with an interval of 2 months, a symptom questionnaire was completed, EBC was collected, and lung function measurements were performed. The acidity of EBC was measured directly after collection. Inflammatory markers interleukin (IL)-6, IL-8, tumor necrosis factor α (TNF-α), and macrophage migration inhibitory factor (MIF) were measured using high sensitivity bead based flow immunoassays. Pulmonary exacerbations were recorded during the study and were defined in two ways. The predictive power of inflammatory markers and the other covariates was assessed using conditionally specified models and a receiver operating characteristic curve (SAS version 9.2). In addition, k-nearest neighbors (KNN) algorithm was applied (SAS version 9.2).Sixty-five percent of the children had one or more exacerbations during the study. The conditionally specified models showed an overall correct prediction rate of 55%. The area under the curve (AUC) was equal to 0.62. The results obtained with the KNN algorithm were very similar.Although there is some evidence indicating that the predictors outperform random guessing, the general diagnostic accuracy of EBC acidity and the EBC inflammatory markers IL-6, IL-8, TNF-α and MIF is low. At present it is not possible to predict pulmonary exacerbations in children with CF with the chosen biomarkers and the method of EBC analysis. The biochemical measurements of EBC markers should be improved and other techniques should be considered.http://europepmc.org/articles/PMC4822839?pdf=render
spellingShingle Marieke van Horck
Ariel Alonso
Geertjan Wesseling
Karin de Winter-de Groot
Wim van Aalderen
Han Hendriks
Bjorn Winkens
Ger Rijkers
Quirijn Jöbsis
Edward Dompeling
Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
PLoS ONE
title Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
title_full Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
title_fullStr Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
title_full_unstemmed Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
title_short Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
title_sort biomarkers in exhaled breath condensate are not predictive for pulmonary exacerbations in children with cystic fibrosis results of a one year observational study
url http://europepmc.org/articles/PMC4822839?pdf=render
work_keys_str_mv AT mariekevanhorck biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT arielalonso biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT geertjanwesseling biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT karindewinterdegroot biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT wimvanaalderen biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT hanhendriks biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT bjornwinkens biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT gerrijkers biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT quirijnjobsis biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy
AT edwarddompeling biomarkersinexhaledbreathcondensatearenotpredictiveforpulmonaryexacerbationsinchildrenwithcysticfibrosisresultsofaoneyearobservationalstudy